Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4D | Q08499 | 1/20 | 0.61 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.61 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.61 |
| ▸ | POLA1 | P09884 | 2/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | MTOR | P42345 | 1/20 | 0.39 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.39 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.39 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.39 |
| ▸ | ST6GAL1 | P15907 | 4/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.36 |
| ▸ | ITGAV | P06756 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20610798 | 1.00 | PDE4D (0.61) | PDE4DPDE3ASLC29A1POLA1LMNA | |
| SCHEMBL4572235 | 0.93 | PDE4D (0.59) | PDE4DPDE3ASLC29A1POLA1LMNA | |
| SCHEMBL25602072 | 0.86 | PDE3A (0.71) | PDE4DPDE3ASLC29A1POLA1LMNA | |
| SCHEMBL25602076 | 0.86 | PDE3A (0.71) | PDE4DPDE3ASLC29A1POLA1LMNA | |
| SCHEMBL20610823 | 0.86 | PDE4D (0.47) | PDE4DPDE3ASLC29A1POLA1LMNA | |
| SCHEMBL31142479 | 0.82 | PDE4D (0.61) | PDE4DPDE3ASLC29A1POLA1LMNA | |
| SCHEMBL4572226 | 0.82 | PDE4D (0.61) | PDE4DPDE3ASLC29A1POLA1LMNA | |
| SCHEMBL15164231 | 0.82 | POLA1 (0.43) | PDE4DPDE3ASLC29A1POLA1LMNA | |
| SCHEMBL382458 | 0.81 | PDE3A (0.75) | PDE4DPDE3ASLC29A1POLA1LMNA | |
| SCHEMBL15788426 | 0.81 | PDE3A (0.75) | PDE4DPDE3ASLC29A1POLA1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160317673-A1 | Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same | SERINA THERAPEUTICS (AL), INC. | 2016-11-03 | — | — | US | disclosed |
| US-20150273074-A1 | Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same | SERINA THERAPEUTICS, INC. | 2015-10-01 | — | — | US | disclosed |
| US-8501899-B2 | Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same | SERINA THERAPEUTICS, INC. (US) | 2013-08-06 | — | — | US | disclosed |
| US-20120123055-A1 | Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same | SERINA THERAPEUTICS, INC. (US) | 2012-05-17 | — | — | US | disclosed |
| US-8101706-B2 | Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same | SERINA THERAPEUTICS, INC. (US) | 2012-01-24 | — | — | US | disclosed |
| US-20100330023-A1 | Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same | SERINA THERAPEUTICS, INC. (US) | 2010-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160317673-A1 | Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same | ERBB3, ERBB2, PANK2 | PDE4D 1858/4885PDE3A 1081/4885SLC29A1 3216/4885 |
| US-20100330023-A1 | Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same | ERBB3, ERBB2, PANK2 | PDE4D 1858/4885PDE3A 1081/4885SLC29A1 3216/4885 |
| US-20150273074-A1 | Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same | ERBB3, ERBB2, PANK2 | PDE4D 1883/4885PDE3A 1086/4885SLC29A1 3341/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.